Search Results - "Hetzel, Gerd R"

Refine Results
  1. 1

    Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis by Luedike, Peter, Rammos, Christos, Pohl, Julia, Heisler, Martin, Totzeck, Matthias, Kleophas, Werner, Hetzel, Gerd R, Kelm, Malte, Hendgen-Cotta, Ulrike, Rassaf, Tienush

    Published in PloS one (20-10-2015)
    “…End stage renal disease (ESRD) patients are characterized by increased morbidity and mortality due to highest prevalence of cardiovascular disease. Macrophage…”
    Get full text
    Journal Article
  2. 2

    Indicators of acute and persistent renal damage in adult thrombotic microangiopathy by Dierkes, Firuseh, Andriopoulos, Nikolaos, Sucker, Christoph, Kuhr, Kathrin, Hollenbeck, Markus, Hetzel, Gerd R, Burst, Volker, Teschner, Sven, Rump, Lars C, Benzing, Thomas, Grabensee, Bernd, Kurschat, Christine E

    Published in PloS one (23-01-2012)
    “…Thrombotic microangiopathies (TMA) in adults such as thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are life-threatening…”
    Get full text
    Journal Article
  3. 3

    Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial by Rassaf, Tienush, Rammos, Christos, Hendgen-Cotta, Ulrike B, Heiss, Christian, Kleophas, Werner, Dellanna, Frank, Floege, Jürgen, Hetzel, Gerd R, Kelm, Malte

    “…Hemodialysis (HD) per se entails vascular dysfunction in patients with ESRD. Endothelial dysfunction is a key step in atherosclerosis and is characterized by…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease by Rammos, Christos, Hendgen-Cotta, Ulrike B, Sobierajski, Julia, Adamczyk, Sarah, Hetzel, Gerd R, Kleophas, Werner, Dellanna, Frank, Kelm, Malte, Rassaf, Tienush

    Published in International journal of cardiology (15-10-2013)
    “…Abstract Background Patients with end-stage renal disease (ESRD) show a high prevalence of cardiovascular disease with arterial stiffness, atherosclerosis and…”
    Get full text
    Journal Article
  6. 6

    Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration by Hetzel, Gerd R., Taskaya, Gediz, Sucker, Christoph, Hennersdorf, Marcus, Grabensee, Bernd, Schmitz, Michael

    Published in American journal of kidney diseases (01-11-2006)
    “…Background: Different methods of regional anticoagulation using citrate in continuous hemofiltration have been described. To date, only such surrogate…”
    Get full text
    Journal Article
  7. 7

    Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome by SUCKER, Christoph, WENZEL, Folker, ZOTZ, Rainer B, HETZEL, Gerd R, SCHARF, Rüdiger E

    Published in Journal of rheumatology (01-09-2006)
    “…We describe a 32-year-old man with secondary antiphospholipid syndrome (APS) who received oral anticoagulation with phenprocoumon after deep vein thrombosis…”
    Get full text
    Journal Article
  8. 8

    Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients by TILLMANN, Frank-Peter, QUACK, Ivo, SCHENK, Ana, GRABENSEE, Bernd, RUMP, Lars C, HETZEL, Gerd R

    Published in Nephrology, dialysis, transplantation (01-08-2012)
    “…After renal transplantation, patients are prone to develop impairments in glucose metabolism. In 2005, the American Diabetes Association published new…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders by Lehmann, Helmar C, Hartung, Hans-Peter, Hetzel, Gerd R, Stüve, Olaf, Kieseier, Bernd C

    Published in Archives of neurology (Chicago) (01-07-2006)
    “…Plasma exchange is a well-established therapeutic procedure commonly used in many neurological disorders of autoimmune etiology. It is thought that the…”
    Get more information
    Journal Article
  11. 11

    Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies? by Sucker, Christoph, Schmitz, Michael, Hetzel, Gerd R, Grabensee, Bernd, Maruhn-Debowski, Beate, Ostojic, Ljerka, Scharf, Rudiger E, Zotz, Rainer B

    Published in Clinical and applied thrombosis/hemostasis (01-08-2009)
    “…Thrombotic microangiopathies are life-threatening disorders characterized by vascular microthromboses, schistocytic hemolytic anemia, and thrombocytopenia…”
    Get more information
    Journal Article
  12. 12
  13. 13

    The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies by Sucker, Christoph, Farokhzad, Firuseh, Kurschat, Christine, Grabensee, Bernd, Scharf, Rudiger E, Zotz, Rainer B, Maruhn-Debowski, Beate, Hetzel, Gerd R

    Published in Clinical and applied thrombosis/hemostasis (01-04-2009)
    “…The 34 Leu (100T) variant of the factor XIII Val34Leu (G100T-) polymorphism slows down fibrinolysis and has been proposed as a thrombotic risk factor. In this…”
    Get more information
    Journal Article
  14. 14

    Effects of candesartan on glomerular hemodynamics and permselectivity in patients with favorable renal allograft function by Hetzel, Gerd R, Plum, Jörg, Fusshöller, Andreas, Voiculescu, Adina, Grünberg, Wiebke, Grabensee, Bernd

    Published in Transplantation (27-03-2005)
    “…Distinct effects of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers on glomerular perfusion and permselectivity are important…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders by Lehmann, Helmar C, Hartung, Hans-Peter, Hetzel, Gerd R, Stüve, Olaf, Kieseier, Bernd C

    Published in Archives of neurology (Chicago) (01-08-2006)
    “…Plasma exchange is a well-established therapeutic procedure commonly used in many neurological disorders of autoimmune etiology. In this second part of our…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Filtration of Macrophage Migration Inhibitory Factor by Luedike, Peter, Rammos, Christos, Pohl, Julia, Heisler, Martin, Totzeck, Matthias, Kleophas, Werner, Hetzel, Gerd R, Kelm, Malte, Hendgen-Cotta, Ulrike, Rassaf, Tienush

    Published in PloS one (20-10-2015)
    “…Background End stage renal disease (ESRD) patients are characterized by increased morbidity and mortality due to highest prevalence of cardiovascular disease…”
    Get full text
    Journal Article
  19. 19

    Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis: e0140215 by Luedike, Peter, Rammos, Christos, Pohl, Julia, Heisler, Martin, Totzeck, Matthias, Kleophas, Werner, Hetzel, Gerd R, Kelm, Malte, Hendgen-Cotta, Ulrike, Rassaf, Tienush

    Published in PloS one (01-10-2015)
    “…Background End stage renal disease (ESRD) patients are characterized by increased morbidity and mortality due to highest prevalence of cardiovascular disease…”
    Get full text
    Journal Article
  20. 20

    The C1542G and G505A Polymorphisms of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Thrombotic Microangiopathies by Sucker, Christoph, Farokhzad, Firuseh, Dahhan, Fieras, Schmitz, Michael, Hetzel, Gerd R., Grabensee, Bernd, Zotz, Rainer B., Scharf, Rudiger E.

    Published in Blood (16-11-2005)
    “…Background Thrombotic microangiopathies are characterized by vascular microthromboses, microangiopathic hemolytic anemia, and thrombocytopenia. Although recent…”
    Get full text
    Journal Article